Addressing challenges in health care and research for people with Down syndrome Read more about Addressing challenges in health care and research for people with Down syndrome
Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium Read more about Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium
Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians Read more about Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians
Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models Read more about Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models
Long-term antipsychotic use, orthostatic hypotension and falls in older adults with Alzheimer's disease Read more about Long-term antipsychotic use, orthostatic hypotension and falls in older adults with Alzheimer's disease
Augmented reality versus standard tests to assess cognition and function in early Alzheimer's disease Read more about Augmented reality versus standard tests to assess cognition and function in early Alzheimer's disease
Beyond Borders: Insights from the GBHI Leadership Retreat in Ghana Read more about Beyond Borders: Insights from the GBHI Leadership Retreat in Ghana
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial Read more about A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial
Innovative Research will Use AI to Understand Dementia's Linguistic Footprint in Latin America Read more about Innovative Research will Use AI to Understand Dementia's Linguistic Footprint in Latin America
Pilot Awards to Advance Global Brain Health and Dementia Projects Read more about Pilot Awards to Advance Global Brain Health and Dementia Projects
